EPW
NVS icon

Evolve Private Wealth’s Novartis NVS Stock Holding History

Evolve Private Wealth’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.43M Sell
21,893
-681
-3% -$102K 0.21% 89
2026
Q1 		$3.45M Buy
22,574
+2,069
+10% +$317K 0.18% 93
2025
Q4 		$2.83M Buy
+20,505
New +$2.69M 0.17% 110

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Evolve Private Wealth's NVS Position: Q2 2026 in Review

Evolve Private Wealth reduced its Novartis (NVS) stake by 3% in Q2 2026, selling an estimated $102K and leaving 21,893 shares worth $3.43M. The position accounts for 0.21% of the portfolio, ranked #89.

Evolve Private Wealth first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.45M in Q1 2026. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Evolve Private Wealth held 21,893 shares of Novartis worth $3.43M as of Q2 2026.
  • Evolve Private Wealth sold 681 Novartis shares in Q2 2026, an estimated $102K.
  • Novartis made up 0.21% of Evolve Private Wealth's portfolio in Q2 2026, its #89 holding.
  • Evolve Private Wealth first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Novartis position peaked at $3.45M in Q1 2026.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.